Skip to main content
Premium Trial:

Request an Annual Quote

Cepheid Licenses Scorpions Technology from DxS

NEW YORK, July 20 (GenomeWeb News) - Cepheid has licensed a probe technology for real-time PCR from DxS, the company said today.

 

Under the agreement, Cepheid may use DxS' Scorpions technology for all markets except clinical diagnostics, wine production, and the detection of chemicals used in agriculture. Scorpions probes contain a PCR primer covalently linked to a fluorescent probe.

 

Cepheid plans to use the technology for food, agriculture, and environmental testing, starting with recreational water testing, combining it with its own SmartCycler and GeneXpert systems.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more